<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/25FCF216-78E6-4AB4-BB67-8A95D26F05B7"><gtr:id>25FCF216-78E6-4AB4-BB67-8A95D26F05B7</gtr:id><gtr:name>University of Veterinary Medicine Budapest</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0BE2F35E-0A74-454A-A8A2-0B43ACFC8BBC"><gtr:id>0BE2F35E-0A74-454A-A8A2-0B43ACFC8BBC</gtr:id><gtr:name>Ceva Animal Health</gtr:name><gtr:address><gtr:line1>Ceva Animal Health</gtr:line1><gtr:line2>90 The Broadway</gtr:line2><gtr:line4>Chesham</gtr:line4><gtr:line5>Bucks</gtr:line5><gtr:postCode>HP5 1EG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AC87F8BC-3044-409A-BCD0-8E29686252CD"><gtr:id>AC87F8BC-3044-409A-BCD0-8E29686252CD</gtr:id><gtr:name>Dept for Env Food &amp; Rural Affairs  DEFRA</gtr:name><gtr:address><gtr:line1>Nobel House 17 Smith Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW1P 3RJ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/25FCF216-78E6-4AB4-BB67-8A95D26F05B7"><gtr:id>25FCF216-78E6-4AB4-BB67-8A95D26F05B7</gtr:id><gtr:name>University of Veterinary Medicine Budapest</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0BE2F35E-0A74-454A-A8A2-0B43ACFC8BBC"><gtr:id>0BE2F35E-0A74-454A-A8A2-0B43ACFC8BBC</gtr:id><gtr:name>Ceva Animal Health</gtr:name><gtr:address><gtr:line1>Ceva Animal Health</gtr:line1><gtr:line2>90 The Broadway</gtr:line2><gtr:line4>Chesham</gtr:line4><gtr:line5>Bucks</gtr:line5><gtr:postCode>HP5 1EG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DCBAEE5-178B-461B-8305-C07F386A8AAF"><gtr:id>7DCBAEE5-178B-461B-8305-C07F386A8AAF</gtr:id><gtr:name>Animal Health &amp; Veterinary Lab Agency</gtr:name><gtr:address><gtr:line1>Woodham Lane</gtr:line1><gtr:line2>New Haw</gtr:line2><gtr:line4>Addlestone</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>KT15 3NB</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B74C23E-C5C9-4201-A4DA-947E70ABAC68"><gtr:id>1B74C23E-C5C9-4201-A4DA-947E70ABAC68</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Langford</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FG018553%2F1"><gtr:id>3FE1BCC7-48FC-4F24-B07C-5716D26E380D</gtr:id><gtr:title>A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G018553/1</gtr:grantReference><gtr:abstractText>Pigs can get many diseases but amongst the most serious are those caused by bacteria that can live in their throats, airways or tonsils but can also cause severe lung (or brain) infections. Large numbers of animals may die quickly (acute infection) or fail to grow normally (chronic infection). Such infections cost the world's pig industry huge sums of money each year. A major problem is that such infections are difficult to diagnose. Some strains of a particular bacterium cause disease and others do not and there is no reliable method to distinguish them. Most experts agree that the best way to control the spread of bacteria is to use a vaccine. However, current vaccines are poor. They do not prevent the spread of bacteria from animal to animal and only work against a few strains. We plan to target four of the most common bacteria that cause infections in pigs: Actinobacillus pleuropneumoniae, Haemophilus parasuis, Mycoplasma hyopneumoniae and Streptococcus suis. The last of these can also cause serious disease in humans such as blood poisoning (septicaemia) and brain infection (meningitis) especially in people who work with pigs. Our aim is to develop (1) tests that can tell which strains can cause disease or not and (2) a single vaccine that protects against more than one of the pig pathogens. We will isolate bacteria from UK pigs and, using genetic techniques, find out how many different sorts of each bacterium are present. The results will be used to develop a diagnostic test and also help in choosing appropriate vaccine candidates. The work will be done in collaboration with partners in the Veterinary Laboratories Agency, Scottish Agricultural College, Agri-Food and Biosciences Institute and Huazhong Agricultural University (Wuhan, China). A successful conclusion to the project (diagnostics and vaccines) will prevent animal suffering (through reduction in infections via vaccination, early diagnosis and treatment, prevention of unnecessary treatment) and save the pig industry substantial amounts of money contributing to the prosperity of the UK.</gtr:abstractText><gtr:technicalSummary>The worldwide economic/welfare burden resulting from bacterial respiratory diseases of pigs is enormous. Control of infection is hampered by the lack of efficacious vaccines and diagnostic tools. Problems include differentiating low/non-virulent/pathogenic strains and the incomplete correlation of phenotype to pathogenic potential. Traditional vaccines (bacterins) typically only protect against homologous strains and do not prevent colonisation. This research program concerns 4 major bacterial respiratory pathogens of pigs: A. pleuropneumoniae, H. parasuis, M. hyopneumoniae and S. suis. All cause substantial mortality and morbidity in pigs worldwide. Additionally S. suis causes severe outbreaks of human infection. There is an international imperative for improved diagnostics and vaccines for all these pathogens. Now is the opportunity to exploit genome data and technical innovations, many of which have been pioneered by the applicants. A multi-centre integrated approach will be used to develop a multivalent vaccine and single platform diagnostic for the 4 bacteria. The largest known collection of disease/non-disease associated UK isolates will be assembled and subjected to MLST and comparative phylogenetics (genomotyping). The data will be used to develop a genotypic based diagnostic. Genetic tools will be developed that allow mutagenesis and/or heterologous antigen expression. Functional genomic screens and follow up studies will identify live attenuated vaccine (LAVs) candidates and conserved immunogenic proteins. The latter will be used as the basis for protein array-based diagnostics and be heterologously expressed either in LAVs or vaccines based on protein glycan coupling technology. The multivalent vaccine and single platform diagnostics will be evaluated in experimental and field trials in collaboration with UK /Chinese veterinarians. The major deliverable will be to reduce animal suffering and the economic and welfare burden of disease in the pig industry.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-11-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1532290</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zoetis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Zoetis collab</gtr:description><gtr:id>4033CB1B-4E59-4709-90B5-92C9CBB69DE9</gtr:id><gtr:impact>Novel diagnostic tests and vaccines.</gtr:impact><gtr:outcomeId>58a1d00195a0e7.44333770-1</gtr:outcomeId><gtr:partnerContribution>Financial contribution to the research.</gtr:partnerContribution><gtr:piContribution>Translational Research.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ceva Animal Health</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ceva collab</gtr:description><gtr:id>1A61A5F9-DE60-44AD-823B-84B07532A447</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>58a1d0a5601660.32540646-1</gtr:outcomeId><gtr:partnerContribution>Provision of clinical samples</gtr:partnerContribution><gtr:piContribution>Diagnostic development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Veterinary Medicine Budapest</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Hungary collab</gtr:description><gtr:id>DCDF4D70-FDBB-4FD3-8C68-5336304DD704</gtr:id><gtr:impact>One paper describing a new serotype of the pig pathogen Actinobacillus pleuropneumoniae</gtr:impact><gtr:outcomeId>58a1d17dc0ef24.52446310-1</gtr:outcomeId><gtr:partnerContribution>Immunological serotyping</gtr:partnerContribution><gtr:piContribution>Whole genome sequence data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>399000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>BBSRC Responsive Mode</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P001262/1</gtr:fundingRef><gtr:id>7FF60316-539E-4A7B-9840-23F66D9F4881</gtr:id><gtr:outcomeId>58a1d27575f998.96865098</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The diagnostic tests we have developed have been applied to clinical samples submitted by veterinary practices to enable disease diagnosis.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>CFE5A389-EEB2-48D2-9CEB-A1FB9A754FD5</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56c1f391503e56.61642350</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed new genetic tools for 4 pig pathogens and also through gene analysis of those pathogens identified prospective vaccine and diagnostic candidates.</gtr:description><gtr:exploitationPathways>Vaccines and diagnostics through industrial partners.</gtr:exploitationPathways><gtr:id>12A70A58-C094-41CB-99B7-936EB988E4FB</gtr:id><gtr:outcomeId>r-9232424441.010155774a0d0a</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>81D5B809-E83B-4A1A-A393-8E8113924D7B</gtr:id><gtr:title>&amp;quot;Pathotyping&amp;quot; Multiplex PCR Assay for Haemophilus parasuis: a Tool for Prediction of Virulence.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>5a5789654a6402.52523411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52A30FB2-409F-4AC9-9FD0-E3F0BECE69F5</gtr:id><gtr:title>Actinobacillus pleuropneumoniae serovar 8 predominates in England and Wales.</gtr:title><gtr:parentPublicationTitle>The Veterinary record</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-4900</gtr:issn><gtr:outcomeId>585d3db7462958.48431554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F3656EA-449E-49D3-98BA-A75F9A8F8303</gtr:id><gtr:title>The use of genome wide association methods to investigate pathogenicity, population structure and serovar in Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>56c1eed5331684.46979913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB3333F9-5EDB-4888-A341-711F5BC420AA</gtr:id><gtr:title>p518, a small floR plasmid from a South American isolate of Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1805a6fa526aa8e2e9818f39fd7908fd"><gtr:id>1805a6fa526aa8e2e9818f39fd7908fd</gtr:id><gtr:otherNames>da Silva GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5a35f8a5adb490.36246207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A57904E-6D99-4A61-B394-6D8A23C18712</gtr:id><gtr:title>Gene content and diversity of the loci encoding biosynthesis of capsular polysaccharides of the 15 serovar reference strains of Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>544a4382b5dbb8.09016227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEBBB743-347D-476B-99E9-D1E8A9C04370</gtr:id><gtr:title>Patterns of antimicrobial resistance in Streptococcus suis isolates from pigs with or without streptococcal disease in England between 2009 and 2014.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3efba8cfcc158dfd3d95941f60ea870f"><gtr:id>3efba8cfcc158dfd3d95941f60ea870f</gtr:id><gtr:otherNames>Hernandez-Garcia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5a578962120321.50355995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>606CE545-C650-4C9F-BE64-B7DCF03FBDF4</gtr:id><gtr:title>Development of a self-replicating plasmid system for Mycoplasma hyopneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>544a43bfb36d94.07332236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4613042C-6067-43F9-83C0-3ECAF8A64689</gtr:id><gtr:title>Whole Genome Sequencing for Surveillance of Antimicrobial Resistance in.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5a2fcd7595a894.58055959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8EFF35E-9CFD-4833-AA2D-C96BDE522619</gtr:id><gtr:title>Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5675e42170598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0343DE04-576F-4670-B8C9-646215C58C10</gtr:id><gtr:title>A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>588b22395d6e70.83991422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>493334FF-0C38-4866-B7C4-8B66998D9BA4</gtr:id><gtr:title>Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5675e18b56409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25B6F0C6-0D86-4EA4-9CC6-3C8386464DC8</gtr:id><gtr:title>Transposon mutagenesis in Mycoplasma hyopneumoniae using a novel mariner-based system for generating random mutations.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bd3c5d25381fa918c81bbe76a4b901c"><gtr:id>0bd3c5d25381fa918c81bbe76a4b901c</gtr:id><gtr:otherNames>Maglennon GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>544a43bf13e060.00308095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88D42F48-4DBE-44D8-8588-D71DF388E251</gtr:id><gtr:title>ICEApl1, an Integrative Conjugative Element Related to ICEHin1056, Identified in the Pig Pathogen Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>585d3e2c270662.19764539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5004CC05-8E95-42CF-B5AF-DF46D1D0455E</gtr:id><gtr:title>The N-linking glycosylation system from Actinobacillus pleuropneumoniae is required for adhesion and has potential use in glycoengineering.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42ea7ffb88b2aca6dd799ae28598e471"><gtr:id>42ea7ffb88b2aca6dd799ae28598e471</gtr:id><gtr:otherNames>Cuccui J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>58a1d3daccf1c7.81906140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75363CB1-8158-4552-A421-19C39E30C312</gtr:id><gtr:title>Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62bbc25410578bdd39f6b567ee8dc269"><gtr:id>62bbc25410578bdd39f6b567ee8dc269</gtr:id><gtr:otherNames>Antenucci F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>5a2fce5835ffe8.50848133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D017F0E-9E65-476C-BC86-4BB0625A2017</gtr:id><gtr:title>Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5675e5fdaf04c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C047118-5CDA-4955-A2CB-D37F6542E952</gtr:id><gtr:title>Characterization of the Actinobacillus pleuropneumoniae SXT-related integrative and conjugative element ICEApl2 and analysis of the encoded FloR protein: hydrophobic residues in transmembrane domains contribute dynamically to florfenicol and chloramphenicol efflux.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5a578965814898.60856816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD791371-071C-4B4E-9221-2BEDE0DEE89A</gtr:id><gtr:title>Apa is a trimeric autotransporter adhesin of Actinobacillus pleuropneumoniae responsible for autoagglutination and host cell adherence.</gtr:title><gtr:parentPublicationTitle>Journal of basic microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00197f85785fc734bc4b9ed4c42fa1ff"><gtr:id>00197f85785fc734bc4b9ed4c42fa1ff</gtr:id><gtr:otherNames>Xiao L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0233-111X</gtr:issn><gtr:outcomeId>544a4382e1c077.03084765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>140AFAD9-DF02-4970-AE35-BB7C5CF23437</gtr:id><gtr:title>A computational strategy for the search of regulatory small RNAs in Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1de72077d7f6e3ec95a886bea0dfd210"><gtr:id>1de72077d7f6e3ec95a886bea0dfd210</gtr:id><gtr:otherNames>Rossi CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>585d3f19ecfdb7.97658962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FE99734-E0AC-484F-9A76-C7AA281ABA3F</gtr:id><gtr:title>Whole genome investigation of a divergent clade of the pathogen Streptococcus suis.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/232e1d2d576604f302e1d6d9230f57c8"><gtr:id>232e1d2d576604f302e1d6d9230f57c8</gtr:id><gtr:otherNames>Baig A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>56c1eed417ec99.54781857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A870F3D9-1661-4CD5-9076-FC1A9E31B816</gtr:id><gtr:title>Corrigendum to 'Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae' [Veterinary Microbiology 178 (2015) 279-282]</gtr:title><gtr:parentPublicationTitle>Veterinary Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3779ddc7ea46e53e4cf08e1dc23387d8"><gtr:id>3779ddc7ea46e53e4cf08e1dc23387d8</gtr:id><gtr:otherNames>Boss? J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675f1cba806a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DE17D15-201F-4F0A-A6F6-90279EDF194C</gtr:id><gtr:title>Surface Polysaccharide Mutants Reveal that Absence of O Antigen Reduces Biofilm Formation of Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feff4f0452bdad254131976e50370306"><gtr:id>feff4f0452bdad254131976e50370306</gtr:id><gtr:otherNames>Hathroubi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>56c1eed4b67968.52951636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>816FA1DA-FDFB-44EB-9DD1-43DD2CD19ED6</gtr:id><gtr:title>Generation of a Tn5 transposon library in Haemophilus parasuis and analysis by transposon-directed insertion-site sequencing (TraDIS).</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebabee70b0e2fa5c626ca468cb266257"><gtr:id>ebabee70b0e2fa5c626ca468cb266257</gtr:id><gtr:otherNames>Luan SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>544a43bf8ec0b7.93096265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC030C06-948A-43E5-ABCA-42F08346685F</gtr:id><gtr:title>Development of a Multiplex PCR Assay for Rapid Molecular Serotyping of Haemophilus parasuis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf051efb0add8489ad05c122866a892"><gtr:id>edf051efb0add8489ad05c122866a892</gtr:id><gtr:otherNames>Howell KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>56c1eed5026242.55334279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FA94032-164E-467B-9661-20AAF4ECDFB9</gtr:id><gtr:title>Multiplex PCR assay for unequivocal differentiation of Actinobacillus pleuropneumoniae serovars 1 to 3, 5 to 8, 10, and 12.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>544a43bea7b521.10409667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACA940E-2C15-4823-A66A-0E8526449FA3</gtr:id><gtr:title>Complete Genome Sequence of MIDG2331, a Genetically Tractable Serovar 8 Clinical Isolate of Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56c1eed3a17253.08895961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32FB59B3-244F-4FF4-98C6-FBDC5816E983</gtr:id><gtr:title>Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cd97b4a1e149c4f95df16a9cd3b6324"><gtr:id>0cd97b4a1e149c4f95df16a9cd3b6324</gtr:id><gtr:otherNames>Li L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>544a43bf4be352.25550278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B154F9AA-FF73-40AF-9CBE-A7FFB2B54DA3</gtr:id><gtr:title>Galleria mellonella is an effective model to study Actinobacillus pleuropneumoniae infection.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61888c1150ea616dc81489f738ca15cd"><gtr:id>61888c1150ea616dc81489f738ca15cd</gtr:id><gtr:otherNames>Pereira MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>5675dcf80bd2a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B39C8004-DA95-470A-A6DF-5A3AE1093244</gtr:id><gtr:title>Necrosis from needlestick injury with live Actinobacillus pleuropneumoniae porcine vaccine.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bbcf5d0da86d140ce2beb31d185f265"><gtr:id>8bbcf5d0da86d140ce2beb31d185f265</gtr:id><gtr:otherNames>Rycroft AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a6f52ce690ad2.06249475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD49DB2E-0F67-4A32-AF15-DF7189CD70D0</gtr:id><gtr:title>The generation of successive unmarked mutations and chromosomal insertion of heterologous genes in Actinobacillus pleuropneumoniae using natural transformation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23bab64b326e5d4392de46aad85a23d4"><gtr:id>23bab64b326e5d4392de46aad85a23d4</gtr:id><gtr:otherNames>Boss? JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f94e94e0222a89</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G018553/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>